Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms. [NA]
A completed clinical trial evaluated the LEFT Smartwatch App as sleep positional therapy for nocturnal gastroesophageal reflux symptoms.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass [NA]
This clinical trial evaluates truncal vagotomy in patients undergoing revisional sleeve gastrectomy to gastric bypass for gastroesophageal r…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Comparative Analysis of Postoperative Manometry Outcomes in Nissen vs Toupet Fundoplication [NA]
A completed clinical trial comparing postoperative esophageal manometry outcomes after Nissen fundoplication versus Toupet fundoplication in…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
This update describes an ongoing clinical trial to assess the safety of vonoprazan exposure during pregnancy and in offspring, currently rec…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Gastroesophageal Reflux Disease Prospective Registry
The Gastroesophageal Reflux Disease Prospective Registry (NCT02479438) sponsored by Baylor Research Institute has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device
An ongoing Vanderbilt-led clinical trial is evaluating a novel mucosal impedance device to assess esophageal epithelium integrity in gastroe…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole [NA]
This clinical trial update notes the completion of a study comparing outpatient follow-up after initiating vonoprazan or esomeprazole for ga…
-
FDA approval · 2025-05-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Devatis Inc.)
FDA approves Pantoprazole Sodium as an Original Application generic product from Devatis Inc. under ANDA 215074.
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Retrospective Observational Study on GERD Management in General Hospitals in Korea
A retrospective observational study assessing the management of gastroesophageal reflux disease in general hospitals in Korea, sponsored by …
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: High Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux [NA]
A clinical trial evaluating high-resolution manometry after partial fundoplication for gastroesophageal reflux and esophageal motility disor…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass [Phase 4]
Phase 4 study assessing the bioavailability of esomeprazole and its effect on pouch pH after gastric bypass; the trial is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Upper GI MM vs Manometry
A completed clinical trial update comparing Upper GI MM with Manometry for gastroesophageal reflux disease.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
A prospective multicentre real-world study is evaluating the efficacy of Danning Tablets for digestive symptoms, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Observationa Study is a Prospective and Multi-institutional Observational Study.
Prospective, multi-institutional observational study sponsored by Jeil Pharmaceutical Co., Ltd. focusing on gastroesophageal reflux disease–…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients
This entry provides an update on a clinical trial comparing transoral fundoplication before sleeve gastrectomy versus Roux-en-Y gastric bypa…
-
FDA approval · 2025-05-07FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for pantoprazole sodium intravenous formulation from Sandoz Inc., expanding the product to include I…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects [Phase 1]
Phase 1 trial of linaprazan glurate/linaprazan in healthy subjects has completed, with results posted; gastroesophageal reflux disease is li…
-
CLINICAL_TRIALS other · 2025-05-01Clinical Trial Update: Famotidine and Antacids for Treatment of Dyspepsia [Phase 4]
Phase 4 clinical trial update indicates recruitment for evaluating famotidine with antacids to treat dyspepsia and gastroesophageal reflux d…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients [Phase 3]
A Phase 3 esophageal pH study evaluating Compound Sodium Alginate Double Action Chewable Tablets in patients with gastroesophageal reflux di…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Cognitive-behavioral Therapy for the Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities. [NA]
A clinical trial exploring cognitive-behavioral therapy for conditions linked to esophageal-brain-gut axis communication abnormalities, curr…
-
FDA label_change · 2025-04-25FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for pantoprazole sodium by Eugia US LLC, resulting in a labeling update for the product.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia [NA]
This clinical trial update states that ARAT for reflux disease after peroral endoscopic myotomy in patients with achalasia is currently enro…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Ultrasound Assessment for Comparison of Gastric Residual Volume After Ingestion of Carbohydrate Drink and Water in Obesity Class II and III Volunteers at Risk of Aspiration [NA]
A completed clinical trial at Prince of Songkla University evaluated gastric residual volume after ingestion of a carbohydrate drink versus …
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Antireflux Ablation of the Cardia Mucosa vs Placebo for the Treatment of Gastroesophageal Reflux Disease [NA]
A completed clinical trial evaluating antireflux ablation of the cardia mucosa versus placebo for gastroesophageal reflux disease.
-
CLINICAL_TRIALS withdrawal · 2025-04-24Clinical Trial Update: Antireflux Ablation Therapy (ARAT) Vs Antireflux Mucosectomy (ARMS) In The Management Of Gastroesophageal Reflux Disease [NA]
A clinical trial evaluating Antireflux Ablation Therapy (ARAT) versus Antireflux Mucosectomy (ARMS) for gastroesophageal reflux disease has …